The promotion of hyperlipidemia by TNF-α is primarily mediated by stimulation of hepatic lipid synthesis [30] and adipose lipolysis, along with suppression of triacylglycerol clearance and inhibition of insulin-stimulated de novo lipogenesis (in adipose tissue) [31]. The gene discussed is INS; the disease is hyperlipidemia.